The Role of Stereotactic Body Radiation Therapy in the Outcomes of Intrahepatic Recurrent Small Hepatocellular Carcinoma
We found SBRT was effective in patients with lesion size of 2-5 cm, with similar results in those with tumor size of 0-2 cm. We suggested that the lesions received over 85.5Gy of biological effective dose with α/β = 10Gy were associated with a higher FFLP.
Authors
- Jianying Lou (ORCID: https://orcid.org/0000-0002-8625-9026)
- Qichun Wei (ORCID: https://orcid.org/0000-0002-8688-5000)
- Jia Yang (ORCID: https://orcid.org/0000-0002-3529-5131)
- Dongjun Dai (ORCID: https://orcid.org/0000-0002-2150-7674)
- Yongjie Shui (ORCID: https://orcid.org/0000-0002-5786-7321)
- Haiyan Chen (ORCID: https://orcid.org/0000-0002-5829-5783)
- Yang Yang (ORCID: https://orcid.org/0000-0002-8392-2830)
- Lihong Liu (ORCID: https://orcid.org/0000-0002-2610-1059)
- Risheng Yu
- Qianqian Yu (ORCID: https://orcid.org/0000-0002-7310-7146)
- Xuan Feng (ORCID: https://orcid.org/0009-0001-5079-4385)
- Yinglu Guo
Institutions
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- The First People's Hospital of Xiaoshan District, Hangzhou (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- Journal of Clinical and Experimental Hepatology
- Published
- 2025-03-31
- DOI
- https://doi.org/10.1016/j.jceh.2025.102561
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China